CarcinoX is a newly developed preventive and cancer risk-modulatory intervention platform engineered using Ultra-nano Inverse Entities (UNIEs)—non-biological, ultra-refined, physicochemically inverted nano-scale constructs derived from carefully processed pathology-associated cellular templates. These templates originate from malignant-state substrates, deep-seated etiological micro-disruption sources, and toxico-metabolic alteration residues. Through a multi-stage transformation process designed to completely eliminate all biological identity, the original templates are converted into bio-inert, stable, inverse-pattern ultra-nano entities that embody physicochemical signatures opposing malignant and pre-malignant cellular deviations. UNIEs are designed to selectively interact with dysregulated or cancer-prone cellular environments, neutralizing malignant drift and supporting the restoration of regulated physiological behavior—while leaving healthy tissues unaffected. As the final construct contains no viable cells, no genetic material, no chemical agents, and no biological residues, CarcinoX represents an exceptionally safe, non-toxic, and non-immunogenic intervention. This paper presents the scientific rationale, conceptual preparation framework, mechanistic basis, and core inverse-signature principles that define CarcinoX as a first-in-class, globally scalable, biologically inert preventive platform for reducing malignant susceptibility and stabilizing cellular regulatory behavior.
Sumeru Ray (Sun,) studied this question.